On Invalid Date, Intercure (NASDAQ: INCR) reported Q3 2022 earnings per share (EPS) of $0.05, up 475% year over year. Total Intercure earnings for the quarter were $2.04 million. In the same quarter last year, Intercure's earnings per share (EPS) was -$0.01.
As of Q1 2023, Intercure's earnings has grown year over year. Intercure's earnings in the past year totalled $9.54 million.
What is INCR's earnings date?
Intercure's earnings date is Invalid Date. Add INCR to your watchlist to be reminded of INCR's next earnings announcement.
What was INCR's revenue last quarter?
On Invalid Date, Intercure (NASDAQ: INCR) reported Q3 2022 revenue of $28.25 million up 46.53% year over year. In the same quarter last year, Intercure's revenue was $19.28 million.
What was INCR's revenue growth in the past year?
As of Q1 2023, Intercure's revenue has grown 95.18% year over year. This is 158.22 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 253.41%. Intercure's revenue in the past year totalled $104.25 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.